Research location
Alzenau in Unterfranken
Germany
Advertisement
Research activity in Alzenau in Unterfranken
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 20 trials and 20 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Alzenau in Unterfranken
20 linked trials · page 1 of 1Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime SleepinessNCT03624920 · 2018-07-12 · 1 site observation
COMPLETED
Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's DiseaseNCT02227355 · 2014-09-01 · 1 site observation
COMPLETED
A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's DiseaseNCT02230904 · 2014-09-01 · 1 site observation
COMPLETED
Azilect® In Wearing-Off (AIWO)NCT02384512 · 2014-01-01 · 1 site observation
COMPLETED
Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s DiseaseNCT01606670 · 2012-05-01 · 1 site observation
COMPLETED
STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)NCT01585298 · 2012-04-29 · 1 site observation
COMPLETED
Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple SclerosisNCT01490840 · 2011-11-01 · 1 site observation
TERMINATED
Fingolimod Versus Interferon Beta 1b in Cognitive SymptomsNCT01333501 · 2011-05-01 · 1 site observation
COMPLETED
Study to Compare Adhesiveness of Two Different Rotigotine Patch FormulationsNCT01338896 · 2011-04-01 · 1 site observation
COMPLETED
Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver SupportNCT01330290 · 2011-03-01 · 1 site observation
COMPLETED
Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisNCT01310166 · 2011-02-01 · 1 site observation
COMPLETED
Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple SclerosisNCT01201356 · 2010-09-13 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA)NCT01285167 · 2010-08-01 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPDNCT01285180 · 2010-08-01 · 1 site observation
COMPLETED
Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) PatientsNCT01127750 · 2010-05-01 · 1 site observation
COMPLETED
Investigation on the Efficacy of WO 2085 Moisturising Cream for Breast Cancer Patients Suffering From Vulvovaginal DrynessNCT03593122 · 2010-01-04 · 1 site observation
COMPLETED
A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful SymptomsNCT01000805 · 2009-11-01 · 1 site observation
COMPLETED
Rivastigmine in Multiple Sclerosis Patients With Cognitive ImpairmentNCT00881205 · 2009-04-01 · 1 site observation
TERMINATED
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesNCT00539487 · 2007-01-01 · 1 site observation
COMPLETED
Transdermal Rotigotine User Surveillance StudyNCT00599339 · 2006-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.